Biologic use in the era of COVID-19

This week, we spoke with Mark Lebwohl, M.D., Waldman Professor and Chair, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.